Inform Genomics

Inform Genomics develops personalized medicine products for cancer supportive care and inflammatory diseases.

Inform Genomics is a private company focused on developing a novel platform of personalized medicine products for cancer supportive care and inflammatory diseases. Their business model leverages existing technology in conjunction with proprietary analytic methods for conducting genome-wide association studies. Product development programs will lead to commercial, single source laboratory tests consisting of SNP clusters that determine the likelihood of individual patient clinical outcomes to drug therapies. The U.S. market opportunity for these differentiated products exceeds $2 billion annually. Inform Genomics is headquartered in Boston, Massachusetts.